sales revenue over the same period last year. The decreased SG&A was mainly in related to the consolidated expense of supporting the Company itself and its overseas subsidiaries’ operation as well as
revenue which was decreased from 3.95% of sales revenue over the same period last year. The SG&A is within reasonable range which was mainly in related to the consolidated expense of supporting the Company
consolidated expense of supporting the Company itself and its overseas subsidiaries’ operation as well as marketing and managing expense to support existing and new customers as compared. 4. Financial Cost For
) Year Status Type Period As Of Audit Financial Statement MD&A Financial Statement Revise 2022 Reviewed Company Q1 31/01/2022 2022 Reviewed Consolidated Q1 31/01/2022 2021 Company Year 31/10
) Year Status Type Period As Of Audit Financial Statement MD&A Financial Statement Revise 2022 Reviewed Company Q2 30/06/2022 2022 Reviewed Consolidated Q2 30/06/2022 2022 Reviewed Company Q1
) Year Status Type Period As Of Audit Financial Statement MD&A Financial Statement Revise 2022 Reviewed Company Q1 31/01/2022 2022 Reviewed Consolidated Q1 31/01/2022 2021 Company Year 31/10
) Year Status Type Period As Of Audit Financial Statement MD&A Financial Statement Revise 2022 Reviewed Company Q1 31/01/2022 2022 Reviewed Consolidated Q1 31/01/2022 2021 Company Year 31/10
) Year Status Type Period As Of Audit Financial Statement MD&A Financial Statement Revise 2022 Reviewed Company Q1 31/01/2022 2022 Reviewed Consolidated Q1 31/01/2022 2021 Company Year 31/10
) found) Year Status Type Period As Of Audit Financial Statement MD&A Financial Statement Revise 2023 Reviewed Company Q3 30/11/2022 2023 Reviewed Consolidated Q3 30/11/2022 2023 Reviewed
Year 31/10/2022 2022 Consolidated Year 31/10/2022 2022 Reviewed Company Q3 31/07/2022 2022 Reviewed Consolidated Q3 31/07/2022 2022 Reviewed Company Q2 30/04/2022 2022